Comprehensive testing can help identify your relevant biomarkers
Every person who might benefit from biomarker-driven cancer treatment deserves that chance. Today, testing using next-generation sequencing, or NGS, can check for multiple biomarkers at the same time using a sample of your tumor tissue or even, in some cases, a blood sample. This type of comprehensive biomarker testing is often covered by private insurance or Medicare/Medicaid plans.
